OneTouch

Hello Heart taps LifeScan for glucometer integration in diabetes management program
By Jonah Comstock | 01:00 pm | March 20, 2019
The company hopes the well-known consumer brand will make its program more accessible.
J&J gets $2.1B offer to sell Lifescan glucometer business
By Jonah Comstock | 03:34 pm | March 16, 2018
Platinum Equity, a Los Angeles-based global investment firm focused on mergers, acquisitions, and operations, has made a binding offer to acquire Johnson & Johnsons' Chesterbrook, Pennsylvania and Zug, Switzerland-based LifeScan business, which sells the OneTouch line of connected and non-connected glucometers.
FDA clears WellDoc's non-RX version of BlueStar, its mobile diabetes management tool
By Heather Mack | 01:35 pm | January 19, 2017
The US Food and Drug Administration has given the green light for a non-prescription version of BlueStar, WellDoc’s mobile diabetes management platform.
Johnson and Johnson RCT aims to find out if a diabetes app can improve A1C
By Jonah Comstock | 10:56 am | May 04, 2015
Johnson & Johnson company LifeScan is launching a clinical trial to determine whether its OneTouch Verio blood glucose meter (or a not-yet-launched version of it) creates a greater reduction in A1C levels when used in conjunction with its companion app.